Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Explore this paper's citation graph
Summary
With continued high rates of adult obesity and DM along with an aging population, NAFLD‐related liver disease and mortality will increase in the United States and strategies to slow the growth ofNAFLD cases and therapeutic options are necessary to mitigate disease burden.
- Type
- review
- Published
- 2017-12-01
- Cited by
- 2,118
- References
- 52
- Access
- Open access
- OpenAlex
- https://openalex.org/W2744982526
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:25048386
Keywords
Nonalcoholic fatty liver disease, Medicine, Cirrhosis, Internal medicine, Population
References
- The current economic burden of cirrhosis.
- Nonalcoholic fatty liver disease.
- Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease
- Trends in the Burden of Non-alcoholic Fatty Liver Disease in a US Cohort of Veterans
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- Nonalcoholic fatty liver disease: a systematic review.
- Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
- Non-Alcoholic Fatty Liver Disease (NAFLD): Is it really a serious condition?
- Non-Alcoholic Fatty Liver Disease and Hepatocellular Cancer: A Systematic Review
- Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
- The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
- The global NAFLD epidemic
- Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States
- Nonalcoholic fatty liver disease.
- Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
- Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
- THE NATURAL HISTORY OF NONALCOHOLIC FATTY LIVER DISEASE WITH ADVANCED FIBROSIS OR CIRRHOSIS: AN INTERNATIONAL COLLABORATIVE STUDY
- Fibrosis Progression in Nonalcoholic Fatty Liver versus Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
Cited by
- Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality
- An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease
- Advances and challenges in cirrhosis and portal hypertension
- Fibrosis imaging: Current concepts and future directions
- Determinants of fibrosis progression and regression in NASH.
- Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity
- Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship
- Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?
- Clinical studies investigating the effect of vitamin E therapy in patients with NASH
- Nonalcoholic steatohepatitis: the new frontier for liver transplantation
- High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance.
- High cholesterol diet modulates macrophage polarization and liver inflammation during early hepatocellular carcinoma progression in zebrafish
- The epidemiology of nonalcoholic steatohepatitis
- Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease
- Dual extraction of mRNA and lipids from a single biological sample
- Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data from a Large US Claims Database
- Is Exercise Beneficial and Safe in Patients with Cirrhosis and Portal Hypertension?
- Optimizing Medication Management for Patients with Cirrhosis: Evidence-Based Strategies and their Outcomes
- Towards a definite mouse model of NAFLD.
- Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury?
Related papers
- Nonalcoholic fatty liver disease and liver transplantation
- Advances in the application of model for end-stage liver disease and MELD-Na scores in liver transplantation
- Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease
- Is severe progressive liver disease caused by alpha‐1‐antitrypsin deficiency more common in children or adults?
- Comparison between MELD and Child- Pugh Scores for liver allocation
- A 2012 clinical update for internists in adult nonalcoholic fatty liver disease.
- Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
- Hepatopulmonary syndrome and portopulmonary hypertension in the model for end‐stage liver disease (MELD) era